Study Highlights Early Health Risks in Children Born Prematurely

A comprehensive longitudinal study by researchers at Vilnius University’s Faculty of Medicine reveals that nearly 80 per cent of all medical diagnoses in children born prematurely are identified before the age of seven, underscoring the urgent need for early, long-term and personalised follow-up care.

Ruta Morkuniene

Led by Dr Rūta Morkūnienė and Prof. Dr Janina Tutkuvienė, the research traces health trajectories from birth through adolescence and into adulthood, demonstrating that the impact of prematurity extends far beyond the neonatal period. The findings carry global relevance: according to the World Health Organization, an estimated 15 million babies are born preterm each year worldwide. While survival rates have improved significantly, the study challenges the assumption that prematurity-related health issues are limited to infancy, highlighting instead a prolonged and evolving health burden.

Most health risks emerge early in life

One of the most extensive analyses of long-term outcomes in preterm children conducted in Lithuania to date, the study draws on medical records from primary healthcare institutions to map health patterns from birth through adolescence.

Unlike many previous studies, the researchers did not restrict their analysis to conditions traditionally linked to prematurity, such as respiratory or neurological disorders.

“I did not set out to record only diagnoses already described in the literature as typical for preterm children,” explains Dr Morkūnienė, a physician and lecturer at Vilnius University. “I documented everything that each child accumulated over time. What emerged was a very broad spectrum of conditions, often involving multiple organ systems and differing greatly from one child to another.”

The findings show that children born prematurely experience a substantially higher overall disease burden than those born at term. Congenital anomalies, nervous system and mental health disorders, tumours, and diseases of the urinary and reproductive systems were diagnosed three to four times more often than in the general population. Disorders of the immune and blood systems occurred up to ten times more frequently, indicating vulnerabilities that persist well beyond early childhood.

A critical window from birth to age seven

Perhaps the study’s most striking insight relates to the timing of diagnosis.

“More than 45 per cent of all diagnoses are made during the first three years of life,” notes Dr Morkūnienė, “and over 30 per cent more are identified between the ages of three and seven.”

By the age of seven, children born prematurely have already accumulated nearly 80 per cent of all diagnoses they are likely to receive by adulthood. The heaviest disease burden falls on children born with very low birth weight (below 1,500 grams), who not only develop more health conditions overall but also a wider range of them.

“Even children born at the same gestational age and with the same birth weight can follow very different health trajectories,” Dr Morkūnienė adds. “Still, the most premature and smallest infants tend to accumulate both more numerous and more diverse health problems.”

Birth weight outweighs gestational age

A key methodological strength of the study lies in its decision to analyse birth weight and gestational age separately, rather than combining them into a single indicator. This distinction revealed that birth weight is more strongly associated with long-term disease burden than gestational age alone.

Children born with lower birth weight grew more slowly and remained shorter and lighter than their peers into adolescence. While their body mass index (BMI) was initially lower, it began to rise sharply from around the age of nine, eventually surpassing that of children born at term.

“This pattern is increasingly recognised internationally,” explains Prof. Tutkuvienė. “Children born prematurely face a higher risk of long-term metabolic conditions, including obesity and diabetes. By analysing birth weight and prematurity separately, we were able to identify which factor plays a more significant role in specific metabolic processes—one of the key novelties of our research.”

Why population-specific growth standards matter

Beyond individual outcomes, the study highlights a broader challenge in paediatric care: the reliance on outdated or poorly adapted growth standards.

“Until recently, Lithuania did not have head circumference reference values for newborns,” says Dr Morkūnienė. “Height and weight standards were often based on limited or decades-old data.”

Using advanced statistical methods developed by Prof. Tim Cole of the UCL Institute of Child Health, the research team established new, population-specific growth norms for Lithuanian newborns, including preterm infants. While international standards are useful for comparison, the researchers warn that they may misrepresent clinically meaningful thresholds in specific populations, potentially leading to delayed or inaccurate diagnoses.

Survival is not the endpoint

Survival outcomes for preterm infants have improved dramatically. In Lithuania, nine out of ten children born prematurely now survive, placing the country among the global leaders in neonatal care. However, the researchers stress that survival alone should not be viewed as the endpoint.

“Prematurity is not a life sentence,” emphasises Prof. Tutkuvienė. “The human body is remarkably resilient. What truly matters is whether health systems provide timely, personalised and long-term support that allows children to reach their full potential.”

Children born preterm, the researchers argue, require extended, multidisciplinary follow-up, involving not only neonatologists and neurologists but also psychologists, speech therapists, physiotherapists and other specialists who can monitor physical, cognitive and emotional development.

“Early childhood is a period of exceptional developmental flexibility,” says Dr Morkūnienė. “When difficulties are identified early, targeted interventions can make a profound difference. Timely support during these formative years can significantly shape long-term health and wellbeing.”

RevealDx Receives FDA Clearance for AI-Powered Lung Nodule Risk Assessment

Seattle, WA – Feb 04: RevealDx, a leader in artificial intelligence solutions for lung nodule characterization, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for RevealAI-Lung, its AI-powered lung nodule risk assessment software. The announcement follows the company’s MDR Certification, received in November 2025.

RevealAI-Lung is designed to assist radiologists in the evaluation of incidental lung nodules by generating a Malignancy Similarity Index (mSI™)—a clinically relevant score that supports more informed follow-up recommendations and aids in earlier and more accurate cancer diagnosis. The technology has been validated on data from more than 1,500 patients across diverse clinical cohorts.

The RevealAI-Lung CADx device offers several differentiated capabilities, including:

  • Significant improvement in radiologist reader performance (AUC delta)

  • Use of real-world National Lung Screening Trial (NLST) data as the reference population

  • Clinically meaningful malignancy risk scoring

  • Industry-first direct integration into PACS, enabling seamless workflow integration

  • Strong generalizability across exam types and patient populations

RevealAI-Lung is available for purchase directly from RevealDx or through its U.S. distributor, Sirona. The company has also announced integrations with Riverain, the leading lung nodule detection company in the U.S., as well as FUJIFILM PACS, further expanding clinical accessibility.

With FDA clearance, RevealAI-Lung is now eligible for Medicare reimbursement under CPT codes 0721T and 0722T, supporting broader clinical adoption.

Commenting on the milestone, Chris Wood, CEO of RevealDx, said,

“We are excited to announce that RevealAI-Lung is now available in the United States. We would like to thank our clinical collaborators for their invaluable support in achieving this milestone. Most importantly, we are enthusiastic about the positive impact RevealAI-Lung can have on patient care by enabling more confident and timely clinical decision-making.”

Budget 2026 Boosts Healthcare Access, Infrastructure, and Skilled Workforce

By:- Dr. Azad Moopen, Founder & Chairman, Aster DM Healthcare

Today’s Budget lays out a thoughtful and forward-looking blueprint for India’s healthcare ecosystem—one that seamlessly integrates innovation, access, capacity expansion and global competitiveness. The Biopharma Shakti initiative, with an outlay of ₹10,000 crore over five years and a clear focus on strengthening research, manufacturing and regulatory capabilities, will play a pivotal role in accelerating India’s journey towards advanced, affordable and globally benchmarked healthcare solutions. The exemption of basic customs duty on 17 critical cancer drugs is a timely and patient-centric measure that will significantly improve access to life-saving therapies while easing the financial burden on families.

The Budget’s strong emphasis on healthcare infrastructure is equally encouraging. The proposed 50 percent capacity expansion of district hospitals, combined with targeted investments in tertiary care through the expansion of NIMHANS 2.0 in North India and the addition of three new AIIMS facilities, will meaningfully strengthen care delivery across both urban and underserved regions. These measures reinforce the government’s commitment to building a more resilient, inclusive and future-ready public health system.

Importantly, the Budget recognises healthcare as a powerful engine of employment and social impact. The announcement of 1,00,000 Allied Health Professionals (AHPs), alongside the training of 1.5 lakh caregivers, supported by structured skilling initiatives, AI-enabled training pathways and digital health programmes, marks a decisive step towards building a large, skilled and future-ready healthcare workforce. This integrated approach will help support an ageing population, specialised care needs and emerging models of care delivery. Together with the continued push for medical hubs, medical value tourism, and a sharper focus on mental and digital health, these initiatives firmly position India as a globally trusted healthcare destination with sustainable long-term growth potential.

Budget 2026: Healthcare Industry Welcomes Focus on Research, Trauma Care, and AYUSH-Integrated Medical Hubs

New Delhi, Feb 01: The Union Budget 2026 has been widely welcomed by India’s healthcare industry for its strategic emphasis on long-term preparedness, research, emergency care, and integrated healthcare systems. Industry leaders highlight that the measures announced in the Budget position India as a global hub for advanced, affordable, and holistic healthcare.

Dr. (Prof.) Purshotam Lal, Chairman, Metro Group of Hospitals, said,

“The ₹10,000 crore commitment to establish a national Biopharma Hub and strengthen non-communicable disease control is both timely and visionary. The proposal to set up trauma centres in every district hospital will enhance emergency response, particularly in semi-urban and rural areas. The creation of 1,000 accredited clinical trial sites bridges the gap between innovation and patient access, while regulatory strengthening enhances India’s credibility in global healthcare.”

Echoing this view, Mr. Abhishek Kapoor, CEO, Regency Healthcare, stated,

“Budget 2026 builds a framework for a more balanced healthcare ecosystem by investing in district-level infrastructure, expanding clinical research networks, and addressing the shortage of allied healthcare professionals. This integrated approach ensures that advanced care and innovation are accessible beyond major urban centres, improving patient outcomes and trust in both public and private healthcare systems.”

Dr. Sharan Shivaraj Patil, Chairman, SPARSH Group of Hospitals, added,

“The establishment of five new Medical Hubs integrated with AYUSH centres marks a major boost for medical tourism and the ‘Heal in India’ initiative. By linking infrastructure, research, and system-wide capacity building, the Budget strengthens India’s position as a global destination for high-quality, affordable treatment.”

Dr. Alok Khullar, Group CEO, RJ Corp Healthcare, commented,

“Budget 2026 demonstrates a strategic vision for healthcare as a driver of economic growth. Expanding clinical trial networks and streamlining regulatory processes will accelerate innovation, improve patient access to advanced therapies, and strengthen India’s global healthcare credibility.”

Mr. Baldev Raj, Founder & CEO, Prius Healthcare, and Vice Chairman, Public Relations Council of India (Delhi Chapter), said,

“The integration of AYUSH centres within five Medical Hubs signals a new era where healthcare is not only a social sector but a pillar of economic growth and global competitiveness. The Budget ensures that infrastructure, skilled manpower, and innovation converge to build a trusted, world-class healthcare system that extends beyond metropolitan centres.”

Key Highlights Welcomed by Industry Leaders:

  • ₹10,000 crore for a national Biopharma Hub and non-communicable disease control

  • Trauma centres in every district hospital to enhance emergency care

  • 1,000 accredited clinical trial sites to accelerate research and innovation

  • Integration of AYUSH centres within five new Medical Hubs to boost medical tourism

  • Emphasis on allied healthcare professionals and skill development

  • Regulatory strengthening to improve compliance, safety, and global credibility

Collectively, these measures are expected to improve healthcare access in Tier-2 and Tier-3 cities, strengthen India’s research and medical tourism capabilities, and reinforce the country’s position as a global healthcare leader.

Budget 2026: AYUSH Hubs to Boost India’s Global Healthcare Leadership

Dr. Puneet Dhawan Hails Budget 2026: “AYUSH-Integrated Medical Hubs to Make India the Global Holistic Healthcare Capital”

New Delhi, Feb 01: Dr. Puneet Dhawan, Co-Chair of the PHDCCI AYUSH Committee and renowned Ayurvedic specialist, today welcomed the government’s announcement in Budget 2026 to establish five new Medical Hubs across India. The initiative aims to integrate AYUSH centers with modern medical infrastructure, promoting holistic healthcare and boosting India’s Medical Value Tourism (MVT) ecosystem.

“This is a transformative step toward ‘Heal in India’,” said Dr. Dhawan. “By integrating AYUSH within these hubs, the long-standing challenge of fragmented care is addressed. International patients can now access both modern diagnostics and traditional healing under one roof.”

Dr. Dhawan highlighted the strategic benefits of the initiative:

  • Scientific Validation: Building a data-driven environment for Ayurvedic clinical outcomes.

  • Global Trust: Leveraging private-sector efficiency and international accreditation for traditional medicine.

  • Economic Growth: Enhancing foreign exchange inflow through specialized wellness and rehabilitation tourism.

“The integration of AYUSH into modern medical hubs not only strengthens India’s healthcare capabilities but also positions the country as a global leader in holistic wellness,” he added.

OpenText Bengaluru Walkathon Unites the City for “Health for All”

Bengaluru,  Jan 31 :The OpenText Bengaluru Walkathon, organised by Samarthanam Trust for the Disabled, was successfully held today, marking the 19th edition of one of India’s longest-running and most inclusive public movements. With OpenText continuing as the Title Sponsor for the second consecutive year, the Walkathon reaffirmed a shared commitment to inclusion, accessibility, and collective well-being, centred on the theme “Health for All.”

56

Over the years, the Bengaluru Walkathon has evolved into a powerful platform bringing together persons with disabilities, senior citizens, students, volunteers, corporates, institutions, NGOs, and community organisations, transforming participation into a visible act of solidarity and shared responsibility.

The Walkathon witnessed participation from over 10,000 people, with a significant representation of persons with disabilities, making it one of India’s most inclusive public movements. Held at Kitturu Rani Chennamma Stadium, the event saw the city come together to demonstrate that inclusion is strongest when it is visible, participatory, and collective.

The Walkathon was led by Dr. Mahantesh G. Kivadasannavar, Founder & Managing Trustee, Samarthanam Trust for the Disabled, along with Mr. Manoj Nagpal, Managing Director & Vice President  Professional Services, OpenText. Their leadership underscored the power of sustained collaboration between the social and corporate sectors in driving long-term, meaningful impact.

The event was graced by Shri C.K. Ramamurthy, MLA, Jayanagar Assembly Constituency and Chairman, Bangalore South District who graced the event as the Chief Guest, and Sri N. Nagaraju, Former Ruling Party Leader of BBMP.

Senior corporate leaders who participated included Ms. Divvya Shetty, Solution Director – Consulting, Blue Yonder; Mr. Rajesh Ramesh, Senior Director Finance, CSC; Mr. Rajesh D.K., AGM, Nabtesco India Private Limited; Ms. Himanshi Jain, Senior People Partner, Hiver; Mr. Vinayak Naik, VP IT Group Executive, FIS; Mr. Punit Sheth, Senior Vice President, SmartStream; and Mr. Sairam Yadalla, Associate Vice President  Software, Voya Global Services Pvt. Ltd.
The event also saw participation from Mr. Janak Bedi, Managing Director & Co-Founder, MyDream Global & MyDream TV, USA.

Leading corporates and institutions participated in large numbers, reflecting strong corporate support for inclusive social action. The Walkathon was further honoured by the presence of Ms. Hilary McGeachy, Consul General, Australian High Commission,

Adding a powerful and inspiring dimension to the event was the participation of the World Champions – Indian Women’s Team, 1st T20 World Cup, Cricket for the Blind (2025), symbolising resilience, excellence, and the transformative role of inclusive sports in nation-building.

Speaking on the occasion, Dr. Mahantesh G. Kivadasannavar said:

“The Walkathon is not about charity it is about visibility, dignity, and participation. When persons with disabilities walk alongside the larger community, society begins to move together. ‘Health for All’ is not a slogan; it is a responsibility to ensure that well-being, opportunity, and inclusion reach everyone.”

Mr. Manoj Nagpal, OpenText, said:

 “The OpenText Bengaluru Walkathon demonstrates the impact of long-term partnerships built on shared values. Health, inclusion, and access are foundational to a strong society, and OpenText is proud to stand with Samarthanam in advancing these principles through sustained action.”

Adding vibrancy and cultural depth to the Walkathon, Team SUNADHA, the arts and culture vertical of Samarthanam Trust for the Disabled, enthralled participants with live performances by singers and musicians with disabilities. Their performances energised the walkers and reinforced the message that art, expression, and inclusion go hand in hand, making the Walkathon not just a public health movement but also a celebration of talent, resilience, and ability.

We look forward to the continued support of the media in amplifying the Walkathon’s message of inclusion, public health, and collective responsibility across platforms.

As the Walkathon moves steadily toward its 20th year, the OpenText Bengaluru Walkathon stands as a living legacy shaped by purpose, strengthened by partnerships, and driven by the vision of Health for All, inspiring communities to walk together toward a more inclusive future.

KIMS Kurnool doctors Dr. Sheikh Mannan & Dr. Kiran Kumar who corrected S-shaped spine

Kurnool, Jan 31: Doctors at KIMS Hospital, Kurnool, have successfully corrected a severe S-shaped spinal deformity in an 18-year-old girl through a highly complex surgery involving the placement of 30 spinal screws.

Photo 3

The patient, a resident of Vamasamudram village in Kurnool district, had been suffering for several years from persistent headaches, abnormal gait, and progressive spinal curvature. Her family, belonging to an economically weaker background, initially sought treatment at a private hospital where she underwent surgery in 2019 for Arnold–Chiari malformation, a congenital condition affecting the brain. While the headaches subsided after that procedure, the spinal deformity continued to worsen over the years, eventually resulting in a pronounced hunchback posture.

Given the high risk associated with corrective spinal surgery in such cases, including the possibility of permanent neurological damage, the patient was referred to KIMS Hospital, Kurnool.

After detailed evaluation, a team led by consultant spine surgeon Dr. Shaik Mannan and Chief Consultant and Head of the Orthopaedics Department Dr. Kiran Kumar decided to perform the surgery under continuous intra-operative neuromonitoring.

Explaining the procedure, Dr. Mannan said the patient had a spinal curvature of nearly 50 degrees extending from the D2 to L4 vertebrae.

“Despite the high risk, we were able to achieve nearly 90–95% correction using 30 specialised screws. The spinal alignment has been restored close to normal. The earlier shoulder imbalance has resolved, both shoulders are now at the same level, and the prominent bony hump on the back has significantly reduced,” he said.

Remarkably, the patient was able to walk independently from the first day after surgery, and her vital functions returned to normal soon after. The surgery was successfully completed with the support of the anaesthesia team comprising Dr. Bhuvana and Dr.Shruthi, along with, critical care Dr. Rajesh Reddy.

Orthopaedic HOD Dr. Kiran Kumar said the procedure marked one of the most complex spinal surgeries performed in the Rayalaseema region and the first successful neuromuscular scoliosis correction of its kind in the area. “This achievement once again highlights the clinical expertise and commitment of KIMS Hospital,” he noted.

KIMS Kurnool Regional COO Siddareddy stated that the entire cost of the surgery was covered under the Arogyasri scheme, making it completely free for the patient. He added that the hospital has performed over 100 highly complex spinal surgeries in the Rayalaseema region, which he described as a matter of pride for the institution.

HPV Vaccination and Regular screening can prevent cervical cancer

Mohali, Jan 31: Cervical cancer is the second most common cancer affecting Indian women, with nearly 1.3 lakh women diagnosed every year. Sadly, most women in India are diagnosed in advanced stages leading to high death rates. This is truly unfortunate as cervical cancer is a preventable cancer. With January being observed as the Cervical Cancer Awareness MonthDr Shweta Tahlan, Senior Consultant, Gynae Onco-Surgery, Fortis Hospital, Mohali, gives us a detailed insight on cervical cancer.

Dr Shweta Tahlan

Cervical cancer occurs in the cells of the cervix, which is the lower part of uterus and most cases are reported in the age group of 35-60 years. Majority of cervical cancers are caused by persistent infection by high-risk strains of Human papilloma virus, and a precancer stage usually precedes the invasive cancer stage. This detailed understanding of the disease makes it a preventable cancer

Prevention and Early detection

HPV vaccination provides the primary prevention against this deadly disease and timely vaccination gives lifelong protection. The recommended age to get vaccinated is between 9 and 26 years of age, although, it can also be given to women up to 45 years of age. HPV vaccine is very safe, effective, widely available and affordable. HPV vaccination is recommended by all medical organizations like WHO, FOGSI and IAP.

Screening tests provide secondary prevention, and it is done by testing cervical smears for abnormal cells (Pap smear & LBC) and presence of HPV (HPV testing). The test is painless and is done in OPD itself. This helps us detect and cure women in precancer stage itself (before cancer is formed). Screening test is recommended for all women over the age of 25 years.

Early detection helps detect women in early stages of cancer. Symptoms of cervical cancer are postcoital vaginal bleeding, persistent vaginal discharge which can be foul-smelling or blood stained, postmenopausal vaginal bleeding, continuous or intermenstrual bleeding, lower abdomen pain or discomfort, urinary troubles and severe back ache.

Treatment

Women in early stages are treated effectively by radical surgery and women diagnosed in advanced stages are treated with radiotherapy, chemotherapy and immunotherapy. Timely treatment from expert oncologists can provide good survival and excellent quality of life.

Widespread HPV vaccination and regular screening can help save many lives. Our target is to save women from this deadly disease and together, we can achieve it.

ISIC Expands Advanced Care with Launch of Integrated Sports Injury Clinic

New Delhi, January 30, 2026: ISIC Multispecialty Hospital, has further strengthened its advanced care portfolio with the launch of a dedicated Sports Injury Clinic—a first-of-its-kind, fully integrated centre designed to deliver comprehensive, patient-centric sports injury management.

Sports Injury Clinic

Going beyond conventional treatment models, the clinic combines professional movement and biomechanical assessments with advanced diagnostics to identify underlying “weak links” in the body that contribute to injury or recurrence. The medical team deploys non-invasive and minimally invasive interventions, including Arthroscopy, Minimally Invasive Spine Surgery (MISS), Platelet-Rich Plasma (PRP), Stem Cell Therapy/BMAC, and Prolotherapy, ensuring precision-led treatment, faster recovery, and durable outcomes. From prehabilitation and accurate diagnosis to surgical excellence and data-driven rehabilitation, the clinic offers a truly end-to-end care ecosystem.

Built on the philosophy that movement is medicine, the Sports Injury Clinic integrates cutting-edge technology with expert-led clinical care to optimise recovery and performance. Central to this approach is the TecnoBody Digital Movement Laboratory, featuring a Digital Mirror Wall, 3D cameras, and real-time biofeedback that provide instant visual cues to correct posture and movement during therapy. Walker View Gait Analysis evaluates walking and running mechanics to identify imbalances and improve posture, while ProKin Balance Platforms deliver advanced proprioceptive training—critical for recovery from injuries such as ankle sprains and ACL tears.

The clinic’s capabilities are further strengthened by hydrotherapy, low-impact recovery programmes, advanced robotics, and 7K visualisation systems, enabling enhanced precision and safety across interventions. Rehabilitation is delivered exclusively by Masters-level physiotherapists, using advanced neuromuscular training techniques, supported by naturopathy and evidence-based clinical nutrition to accelerate healing, optimise performance, and build long-term resilience.

The launch comes at a time when sports-related injuries are rising steadily across India. Studies suggest that nearly half of individuals engaged in regular physical activity experience musculoskeletal injuries, most commonly affecting the knees (28%), ankles (18%), shoulders (10%), and spine (13%). Notably, ACL injuries among young athletes have surged by over 400% in the past two decades, driven by early sports specialisation and inadequate rehabilitation. Experts highlight that the lack of integrated sports medicine infrastructure often results in incomplete recovery, repeated injuries, and shortened athletic careers—gaps the ISIC Sports Injury Clinic aims to address.

Commenting on the launch, Ms. Sugandh Ahluwalia, Chief Strategy Officer, ISIC Multispecialty Hospital, said,
“ISIC’s legacy has always been rooted in restoring movement and function through advanced spine and orthopaedic care. The Sports Injury Clinic is a natural extension of this philosophy, where prehabilitation and rehabilitation are not add-ons but central to recovery. By integrating early conditioning, precise movement analysis, and masters-led rehabilitation, we are enabling athletes to be better prepared before injury or surgery and supported well beyond it—ensuring recovery that is stronger, safer, and sustainable.”

Dr. Ashish Chandra, Chief Operating Officer, ISIC Multispecialty Hospital, added,
“As ISIC continues to evolve, our focus remains on building advanced, future-ready centres of care. The Sports Injury Clinic reflects this vision—bringing together minimally invasive surgery, robotic rehabilitation, digital motion labs, hydrotherapy, and regenerative therapies under one roof. This integrated ecosystem allows us to offer athletes access to sports medicine and recovery protocols on par with leading global institutions.”

With the launch of the Sports Injury Clinic, ISIC Multispecialty Hospital reinforces its position as a centre of excellence in advanced orthopaedic and sports medicine care, offering athletes a comprehensive, future-ready platform dedicated to recovery, performance, and long-term athletic health.

Budget 2026 Can Strengthen Early and Accessible Fertility Care: Abhishek Aggrawal

Abhishek Aggrawal, CEO, Birla Fertility & IVF

“India’s health system has made significant progress in prevention, diagnostics, and treatment. Fertility care now needs to be formally integrated into this framework as part of comprehensive family health planning.

Budget 2026 has an opportunity to enable earlier and more efficient fertility care through practical measures. Integrating fertility screening into preventive health programmes and extending insurance coverage to diagnostics and early stage interventions would allow people to seek care sooner, when treatment is more effective and costs are better controlled.

Access must be matched with quality. National standards for fertility laboratories, structured training for embryologists, and consistent clinical protocols are essential to delivering safe and reliable outcomes across the country.

These are targeted investments with long term returns. Strong fertility care infrastructure supports family formation, demographic stability, and a more resilient healthcare system, making it a logical inclusion in India’s health and economic planning.”